330 related articles for article (PubMed ID: 17549570)
1. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Nos C; Lesieur B; Clough KB; Lecuru F
Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570
[TBL] [Abstract][Full Text] [Related]
2. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
3. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
[TBL] [Abstract][Full Text] [Related]
4. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
5. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
7. [Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
Pavlista D; Eliška O
Ceska Gynekol; 2012 Jun; 77(3):251-4. PubMed ID: 22779729
[TBL] [Abstract][Full Text] [Related]
8. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection.
Nos C; Kaufmann G; Clough KB; Collignon MA; Zerbib E; Cusumano P; Lecuru F
Ann Surg Oncol; 2008 Sep; 15(9):2550-5. PubMed ID: 18618185
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
Salmon RJ; Fried D
Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
[TBL] [Abstract][Full Text] [Related]
11. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
13. [Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].
Mignotte H; Treilleux I; Chassagne-Clément C; Bem C; Lopez R; Martin X; Brémond A
Bull Cancer; 2000 Jul; 87(7-8):600-3. PubMed ID: 10969216
[TBL] [Abstract][Full Text] [Related]
14. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
15. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
[TBL] [Abstract][Full Text] [Related]
16. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
van Wessem KJ; Meijer WS
Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
[TBL] [Abstract][Full Text] [Related]
18. Is axillary reverse mapping feasible in breast cancer patients?
Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
[TBL] [Abstract][Full Text] [Related]
19. Axillary reverse mapping: five-year experience.
Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of lymphatic mapping with sub-areolar injection of patent blue dye, in the typification of breast cancer].
Gallegos-Hernández JF; Chávez-García M
Rev Invest Clin; 2003; 55(4):407-11. PubMed ID: 14635604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
